BN Business News
Add your company to Business Communicator →

Business · 04/11/20261 min read

Opinion/decision on a plan of investigation for children (PIP): Joenja, leniolisib phosphate, type of decision: PM: Decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, number of PIP: EMA/PE/0000248263

Summary

Opinion/decision on a PIP: Joenja, leniolisib phosphate, type of decision: PM: Decision on the application for modification of an agreed PIP, therapeutic area:...

Original source language: EMA — Paediatric Investigation PlansOpen original release →

Explore insights

Business insights →